26-Hydroxycholesterol

26-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 26-hydroxycholesterol is associated with abnormalities such as Cardiovascular Diseases, Vascular Diseases, Metabolic syndrome, Obesity and Fatty Streak, Arterial. The involved functions are known as Oxidation, phospholipase activity, glucose metabolism, Binding (Molecular Function) and Regulation. 26-hydroxycholesterol often locates in Immune system, Body tissue, Extracellular, Protoplasm and Back. The associated genes with 26-Hydroxycholesterol are Homologous Gene, chylomicron remnant, Receptor Gene, Alleles and D3 compound. The related lipids are 27-hydroxycholesterol, Hydroxycholesterols, Lysophosphatidylcholines, Total cholesterol and Lipopolysaccharides. The related experimental models are Knock-out and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of 26-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 26-Hydroxycholesterol?

26-Hydroxycholesterol is suspected in hypercholesterolemia, Obesity, Atherosclerosis, Metabolic syndrome, Neurodegenerative Disorders, Dyslipidemias and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 26-Hydroxycholesterol

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Alzheimer Disease D000544 76 associated lipids
Alcoholism D000437 27 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 26-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 26-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 26-Hydroxycholesterol?

Transgenic Model

Transgenic Model are used in the study 'Cholesterol and breast cancer pathophysiology.' (Nelson ER et al., 2014) and Transgenic Model are used in the study 'Obesity, cholesterol metabolism, and breast cancer pathogenesis.' (McDonnell DP et al., 2014).

Knock-out

Knock-out are used in the study 'The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.' (Umetani M et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 26-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 403
Authors Title Published Journal PubMed Link
Karuna R et al. Dopant assisted-atmospheric pressure photoionization (DA-APPI) liquid chromatography-mass spectrometry for the quantification of 27-hydroxycholesterol in plasma. 2009 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:19121981
Escher G et al. Role of CYP27A1 in progesterone metabolism in vitro and in vivo. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19671838
Li T and Chiang JY Regulation of bile acid and cholesterol metabolism by PPARs. 2009 PPAR Res pmid:19636418
Mateos L et al. Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro. 2009 Brain Pathol. pmid:18503570
Wang Y et al. Targeted lipidomic analysis of oxysterols in the embryonic central nervous system. 2009 Mol Biosyst pmid:19381367
Trousson A et al. Cross-talk between oxysterols and glucocorticoids: differential regulation of secreted phopholipase A2 and impact on oligodendrocyte death. 2009 PLoS ONE pmid:19956653
Zhou C et al. The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. 2009 Nucl Recept Signal pmid:19240808
Prasanthi JR et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. 2009 Mol Neurodegener pmid:19126211
Koschack J et al. Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals. 2009 Neurobiol. Aging pmid:18061309
Mathieu JM et al. Medical bioremediation of age-related diseases. 2009 Microb. Cell Fact. pmid:19358742
Lange Y et al. Regulation of fibroblast mitochondrial 27-hydroxycholesterol production by active plasma membrane cholesterol. 2009 J. Lipid Res. pmid:19401598
van den Kommer TN et al. Total cholesterol and oxysterols: early markers for cognitive decline in elderly? 2009 Neurobiol. Aging pmid:17888546
Kim WS et al. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. 2009 J. Alzheimers Dis. pmid:19158428
Hirayama T et al. Serum concentration of 27-hydroxycholesterol predicts the effects of high-cholesterol diet on plasma LDL cholesterol level. 2009 Hepatol. Res. pmid:19208035
Tang W et al. Glucocorticoid receptor-mediated upregulation of human CYP27A1, a potential anti-atherogenic enzyme. 2008 Nov-Dec Biochim. Biophys. Acta pmid:18817892
Patel MB et al. Liver x receptor: a novel therapeutic target. 2008 Mar-Apr Indian J Pharm Sci pmid:20046702
Mosig S et al. Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism. 2008 BMC Med Genomics pmid:19040724
de Vogel-van den Bosch HM et al. A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:18356535
Weiner MF et al. Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injury. 2008 Brain Inj pmid:18568715
Ghribi O Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle. 2008 J. Alzheimers Dis. pmid:19096164
Cheng D et al. Regulation of alpha-synuclein expression by liver X receptor ligands in vitro. 2008 Neuroreport pmid:18841091
Lange Y et al. Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase. 2008 J. Biol. Chem. pmid:18024962
Zhang JR et al. Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. 2008 J. Clin. Invest. pmid:18483620
DuSell CD et al. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. 2008 Mol. Endocrinol. pmid:17872378
Crosignani A et al. Plasma oxysterols in normal and cholestatic children as indicators of the two pathways of bile acid synthesis. 2008 Clin. Chim. Acta pmid:18538136
Lee CY et al. Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample. 2008 Free Radic. Biol. Med. pmid:18226605
Rantham Prabhakara JP et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells. 2008 J. Neurochem. pmid:19014385
Yoshida T et al. Determination of key intermediates in cholesterol and bile acid biosynthesis by stable isotope dilution mass spectrometry. 2008 Anal Chem Insights pmid:19609389
Griffiths WJ et al. Discovering oxysterols in plasma: a window on the metabolome. 2008 J. Proteome Res. pmid:18605750
Sharma S et al. Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. 2008 Neurobiol. Dis. pmid:18775495
DuSell CD and McDonnell DP 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling. 2008 Trends Pharmacol. Sci. pmid:18722677
DiBlasio-Smith EA et al. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. 2008 J Transl Med pmid:18925943
Szatmari I and Nagy L Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. 2008 EMBO J. pmid:18716631
Duron E and Hanon O Vascular risk factors, cognitive decline, and dementia. 2008 Vasc Health Risk Manag pmid:18561512
Chen W et al. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. 2007 Cell Metab. pmid:17189208
Hojo K et al. Determination of total cholesterol in serum by high-performance liquid chromatography with electrochemical detection. 2007 J Chromatogr A pmid:17723233
Meaney S et al. Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid. 2007 J. Lipid Res. pmid:17251592
Gueguen Y et al. Compared effect of immunosuppressive drugs cyclosporine A and rapamycin on cholesterol homeostasis key enzymes CYP27A1 and HMG-CoA reductase. 2007 Basic Clin. Pharmacol. Toxicol. pmid:17516993
Li T et al. PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. 2007 J. Lipid Res. pmid:17088262
Teunissen CE et al. 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. 2007 J. Neurosci. Res. pmid:17410599
Hansson M et al. Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase. 2007 J. Intern. Med. pmid:17444890
Jiang X et al. Characterization of oxysterols by electrospray ionization tandem mass spectrometry after one-step derivatization with dimethylglycine. 2007 Rapid Commun. Mass Spectrom. pmid:17154356
Burkard I et al. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. 2007 Atherosclerosis pmid:17107679
Luomala M et al. Osteopontin levels are associated with cholesterol synthesis markers in mildly hypercholesterolaemic patients. 2007 Acta Cardiol pmid:17536607
Crosignani A et al. Changes in classic and alternative pathways of bile acid synthesis in chronic liver disease. 2007 Clin. Chim. Acta pmid:17482152
Li X et al. Biosynthesis of the regulatory oxysterol, 5-cholesten-3beta,25-diol 3-sulfate, in hepatocytes. 2007 J. Lipid Res. pmid:17890683
Umetani M et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. 2007 Nat. Med. pmid:17873880
van den Bosch HM et al. Gene expression of transporters and phase I/II metabolic enzymes in murine small intestine during fasting. 2007 BMC Genomics pmid:17683626
Björkhem I Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. 2006 J. Intern. Med. pmid:17116000
Pikuleva IA Cholesterol-metabolizing cytochromes P450. 2006 Drug Metab. Dispos. pmid:16434543
Guéguen Y et al. Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat. 2006 Arch. Toxicol. pmid:16231126
Klass DM et al. Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects. 2006 Aliment. Pharmacol. Ther. pmid:16573792
Rojo L et al. Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease. 2006 J. Biomed. Biotechnol. pmid:17047312
Thelen KM et al. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. 2006 J Clin Pharmacol pmid:16809807
Gong H and Williams JR Synthesis of the aglycone of the shark repellent pavoninin-4 using remote functionalization. 2006 Org. Lett. pmid:16706499
Björkhem I et al. Oxysterols and Alzheimer's disease. 2006 Acta Neurol. Scand., Suppl.c pmid:16866910
Larsson DA et al. Oxysterol mixtures, in atheroma-relevant proportions, display synergistic and proapoptotic effects. 2006 Free Radic. Biol. Med. pmid:16934673
Dushkin MI et al. Effects of hydroxysterols and atorvastatin on lipopolysaccharide-induced secretion of tumor necrosis factor and interleukin-10 by mouse macrophages. 2006 Bull. Exp. Biol. Med. pmid:16984105
Thelen KM et al. Effect of pravastatin on plasma sterols and oxysterols in men. 2006 Eur. J. Clin. Pharmacol. pmid:16385401
Luomala M et al. Plasma-soluble CD40 is related to cholesterol metabolism in patients with moderate hypercholesterolemia. 2006 Scand. Cardiovasc. J. pmid:17012138
Holzapfel J et al. PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease. 2006 Neurosci. Lett. pmid:16979821
Kummerow FA et al. 27-Hydroxycholesterol causes remodeling in endothelial cell membrane lipid composition comparable to remodeling in the failed vein grafts of CABG patients. 2006 Life Sci. pmid:16154158
Lemaire-Ewing S et al. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. 2005 Cell Biol. Toxicol. pmid:16142584
Babiker A et al. Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acid. 2005 Scand. J. Clin. Lab. Invest. pmid:16081359
Heverin M et al. Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. 2005 J. Lipid Res. pmid:15741649
Hall EA et al. Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells. 2005 Biochim. Biophys. Acta pmid:15863358
Hansson M et al. Regulation of sterol 27-hydroxylase in human monocyte-derived macrophages: up-regulation by transforming growth factor beta1. 2005 Biochim. Biophys. Acta pmid:15708352
Davies JD et al. Adipocytic differentiation and liver x receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells. 2005 J. Biol. Chem. pmid:15548517
Del Puppo M et al. A minimally invasive technique for the evaluation of the regulatory steps of the two major pathways of bile acid synthesis. 2005 Clin. Chim. Acta pmid:15820474
Bohr IJ Does cholesterol act as a protector of cholinergic projections in Alzheimer's disease? 2005 Lipids Health Dis pmid:15949039
Zhu Y et al. Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR). 2005 Cardiovasc. Res. pmid:16099444
Hall EA et al. Mitochondrial cholesterol transport: a possible target in the management of hyperlipidemia. 2005 Lipids pmid:16477808
von Bahr S et al. Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy. 2005 J. Pediatr. Gastroenterol. Nutr. pmid:15795599
Meaney S Is C-26 hydroxylation an evolutionarily conserved steroid inactivation mechanism? 2005 FASEB J. pmid:16051688
Matyash V et al. Sterol-derived hormone(s) controls entry into diapause in Caenorhabditis elegans by consecutive activation of DAF-12 and DAF-16. 2004 PLoS Biol. pmid:15383841
Szanto A et al. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. 2004 Mol. Cell. Biol. pmid:15340076
Zhou Q et al. 27-Hydroxycholesterol inhibits neutral sphingomyelinase in cultured human endothelial cells. 2004 Life Sci. pmid:15261762
Holdenrieder S et al. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke? 2004 Neurosci. Lett. pmid:15351449
Strömsten A et al. Studies on the mechanism of accumulation of cholesterol in the gallbladder mucosa. Evidence that sterol 27-hydroxylase is not a pathogenetic factor. 2004 J. Hepatol. pmid:14672608
Kölsch H et al. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. 2004 Neurosci. Lett. pmid:15364416
Leoni V et al. Diagnostic use of cerebral and extracerebral oxysterols. 2004 Clin. Chem. Lab. Med. pmid:15061359
Alessandrini L et al. Clemmensen reduction of diosgenin and kryptogenin: synthesis of [16,16,22,22,23,23-(2)H(6)]-(25R)-26-hydroxycholesterol. 2004 Steroids pmid:15582533
Burkard I et al. Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry. 2004 J. Lipid Res. pmid:14729854
Brown J et al. Differential expression of cholesterol hydroxylases in Alzheimer's disease. 2004 J. Biol. Chem. pmid:15148325
Zhang J et al. The steroidal analog GW707 activates the SREBP pathway through disruption of intracellular cholesterol trafficking. 2004 J. Lipid Res. pmid:14617742
Heverin M et al. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. 2004 J. Lipid Res. pmid:14523054
Honda A et al. Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits. 2004 Metab. Clin. Exp. pmid:14681840
Meaney S et al. Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: increased levels in patients with pulmonary alveolar proteinosis. 2004 J. Lipid Res. pmid:15466366
Teunissen CE et al. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. 2003 Jan-Feb Neurobiol. Aging pmid:12493560
Meaney S et al. On the origin of the cholestenoic acids in human circulation. 2003 Steroids pmid:12957664
Tuomainen TP et al. Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man. 2003 Free Radic. Biol. Med. pmid:14556856
Hansson M et al. Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages. 2003 Biochim. Biophys. Acta pmid:12581873
Leoni V et al. Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers. 2003 J. Lipid Res. pmid:12562838
Guan JZ et al. Clofibrate, a peroxisome-proliferator, enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation. 2003 Tohoku J. Exp. Med. pmid:14690017
Frolov A et al. NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols. 2003 J. Biol. Chem. pmid:12719428
Souidi M et al. Effects of dietary 27-hydroxycholesterol on cholesterol metabolism and bile acid biosynthesis in the hamster. 2003 Can. J. Physiol. Pharmacol. pmid:14614521
Pikuleva I and Javitt NB Novel sterols synthesized via the CYP27A1 metabolic pathway. 2003 Arch. Biochem. Biophys. pmid:14622972
Ciuffreda P et al. Synthesis of deuterated isotopomers of 7alpha- and (25R,S)-26-hydroxycholesterol, internal standards for in vivo determination of the two biosynthetic pathways of bile acids. 2003 Steroids pmid:14625005
Escher G et al. Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux. 2003 J. Biol. Chem. pmid:12531903
Yoshida T et al. Origin of oxysterols in hepatic bile of patients with biliary infection. 2003 Am. J. Gastroenterol. pmid:14572579